Not available
Quote | IDEX Corporation (NYSE:IEX)
Last: | $223.28 |
---|---|
Change Percent: | 0.63% |
Open: | $223.23 |
Close: | $223.28 |
High: | $225.385 |
Low: | $220.7 |
Volume: | 486,624 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
News | IDEX Corporation (NYSE:IEX)
2024-04-24 13:48:08 ET IDEX Corporation (IEX) Q1 2024 Earnings Conference Call April 24, 2024 10:30 AM ET Company Participants Wendy Palacios – Vice President-FP&A and Investor Relations Eric Ashleman – Chief Executive Officer and President Abhi...
2024-04-24 12:04:16 ET Revenue growth has been positive due to strong price/cost performance. Despite market challenges, cash flow increased by 6%. Operating expenses decreased, and net income margin slightly declined. Management focused on cost management and risk assessment, with market ris...
Message Board Posts | IDEX Corporation (NYSE:IEX)
Subject | By | Source | When |
---|---|---|---|
NetworkNewsWire: NetworkNewsBreaks Ideanomics (NASDAQ: IDEX) Releases Q1 2021 Financial Report Idea | NetworkNewsWire | investorshangout | 05/18/2021 9:08:12 PM |
whytestocks: $IEX News Article - IDEX Corporation to Webcast Fourth Quarter 2019 Earnings Call | whytestocks | investorshangout | 12/20/2019 8:30:43 PM |
RBC Capital downgraded IDEX today. 11 valuation models | ValueInvestor15 | investorshub | 12/07/2016 8:13:17 PM |
Every valuation model shows IDEX is overvalued before | ValueInvestor15 | investorshub | 10/17/2016 3:36:02 PM |
jim50: IEX Stock Gapped up +0.03 $IEX Last Price 76.27 Day High 76.47 Day Low 75.12 Change +1.25 Vol | jim50 | investorshangout | 03/31/2015 7:13:55 AM |
News, Short Squeeze, Breakout and More Instantly...
2024-04-24 12:04:16 ET Revenue growth has been positive due to strong price/cost performance. Despite market challenges, cash flow increased by 6%. Operating expenses decreased, and net income margin slightly declined. Management focused on cost management and risk assessment, with market ris...
First Quarter 2024 Highlights (All comparisons are against the first quarter of 2023 unless otherwise noted) Sales of $801 million, down 5% overall and 6% organically, in line with expectations Reported diluted EPS of $1.60, down 13%, and adjusted diluted EPS of $1.88, down 10%,...
Kiniksa Pharmaceuticals Ltd. (KNSA) is expected to report $-0.14 for Q1 2024 Agree Realty Corporation (ADC) is expected to report $1.01 for Q1 2024 1st Colonial Bancorp Inc (FCOB) is expected to report for Q1 2024 Equity Residential of Beneficial Interest (EQR) is expected to report $...